Köhler Hugo Fontan, Maciel Maria do Socorro, Collins Juan Donoso, Rozenowicz Renato de Lima, Netto Mário Mourão
Department of Breast Surgery, Hospital A. C. Camargo, São Paulo, Brazil.
Sao Paulo Med J. 2010 May;128(3):125-9. doi: 10.1590/s1516-31802010000300004.
Lobular carcinoma is the second most common type of breast neoplasia and has unique clinical and pathological features. Our aim was to evaluate prognostic factors for this type of breast cancer.
Retrospective study at a tertiary oncological institution.
162 patients diagnosed and treated between January 1985 and January 2002 were included. The inclusion criteria were: absence of previous treatment, histological diagnosis of lobular carcinoma, no previous history of breast cancer and minimum follow-up of 36 months.
In univariate analysis, the following factors were statistically significant: clinical stage T (P = 0.0005), clinical stage N (P = 0.0014), neoadjuvant chemotherapy (P = 0.0008), primary tumor size (P < 0.0001), vascular invasion (P < 0.0001), lymphatic invasion (P = 0.0004), neural invasion (P = 0.0004), skin invasion (P < 0.0001), capsular transposition (P = 0.0008), lymph node ratio (P < 0.0001), estrogen receptor expression (P = 0.0186), progesterone receptor expression (P = 0.0286), pathological stage T (P < 0.0001), pathological stage N (P < 0.0001), adjuvant chemotherapy (P < 0.0001) and postoperative hormone therapy (P = 0.0367). After grouping the variables, multivariate analysis was performed. Presence of lymph node metastases, capsular transposition, lymph node ratio and postoperative hormone therapy remained significant.
In this series, the most important prognostic factors for lobular carcinoma of the breast seemed to relate to lymph node status and presence of capsular transposition. Factors relating to axillary involvement, capsular transposition and hormone therapy were significant for survival.
小叶癌是第二常见的乳腺肿瘤类型,具有独特的临床和病理特征。我们的目的是评估这类乳腺癌的预后因素。
在一家三级肿瘤机构进行的回顾性研究。
纳入1985年1月至2002年1月期间诊断并接受治疗的162例患者。纳入标准为:无既往治疗史、小叶癌组织学诊断、无乳腺癌既往史且最短随访36个月。
单因素分析中,以下因素具有统计学意义:临床分期T(P = 0.0005)、临床分期N(P = 0.0014)、新辅助化疗(P = 0.0008)、原发肿瘤大小(P < 0.0001)、血管侵犯(P < 0.0001)、淋巴管侵犯(P = 0.0004)、神经侵犯(P = 0.0004)、皮肤侵犯(P < 0.0001)、包膜移位(P = 0.0008)、淋巴结比率(P < 0.0001)、雌激素受体表达(P = 0.0186)、孕激素受体表达(P = 0.0286)、病理分期T(P < 0.0001)、病理分期N(P < 0.0001)、辅助化疗(P < 0.0001)及术后激素治疗(P = 0.0367)。对变量进行分组后,进行多因素分析。淋巴结转移、包膜移位、淋巴结比率及术后激素治疗仍具有显著性。
在本系列研究中,乳腺小叶癌最重要的预后因素似乎与淋巴结状态及包膜移位的存在有关。与腋窝受累、包膜移位及激素治疗相关的因素对生存具有显著性。